Alaska Liver Disease ECHO
Learn together, Care together.
The Liver Disease and Hepatitis Program and consultants from Pharmacy, Diabetes and Behavioral Health have partnered with the Northwest Portland Area Indian Health Board to create AK Liver Disease ECHO, a comprehensive program to assist Tribal Healthcare Providers to provide better care of Alaska Native/American Indian patients with liver disease.
Starting in 2024 Alaska Liver Disease ECHO has merged with LiverConnect ECHO, please click here for more information.
Please contact us about submitting a case presentation or for any questions.
Past Session Recordings:
- 2023 Liver Disease ECHO Wrap Up, Resources, Cases, and Q&A, didactic recording
- Being Alert to DILI, didactic recording
- Stressing Importance of Exercise as NAFLD Treatment – Now that It is Getting Dark and Cold, didactic recording
- Importance of diabetes management in NAFLD/NASH, didactic recording
- Recognizing Common Autoimmune Liver Diseases Seen in AN/AI people, didactic recording
- Importance of diabetes management in NAFLD/NASH, didactic recording
- Emphasizing Nutrition for Liver Health, didactic recording
- Effective Strategies for Alcohol Use Disorder Screening – When, Where, and How to Implement, didactic recording
- Addressing Safe Medication Prescribing, didactic recording/li>
- Decreasing Morbidity and Mortality in Cirrhosis, didactic recording
- Ensuring Regular HCC Surveillance, didactic recording
- Metabolic Associated Fatty Liver Disease and FIB4, didactic recording
- Challenges Faced with Screening and Linkage to Care/Treatment for Hepatitis C, didactic recording
- HCC Surveillance – Are We Doing Enough?, didactic recording
- Medication for Addiction Treatment (MAT), didactic recording
- Screening for Alcohol Use Disorder, didactic recording
- Trauma Informed Care and Liver Disease, didactic recording
- Most Common Liver Toxic Drugs (and how to use LiverTox website), didactic recording
~This project is supported by a grant from the Northwest Portland Area Indian Health Board and funding is provided from the HHS Secretary’s Minority HIV/AIDS Fund.